As the African continent continues to grapple with the persistent threat of mosquito-borne diseases like malaria, a team of young scientists has developed a natural mosquito-repellent cream.
Read more
biotechnologyFAS BioCamp 2026 is open for applications — a two-week intensive where Africa's most ambitious scientists learn to build a biotech company, from idea to proof-of-concept. Apply by Feb 28.
Read more
researchThe 2025 FAS Bioscience Market Analysis Fellowship has concluded — 80 fellows across 12 African countries mapping the demand for locally manufactured, research-grade lab consumables.
Read more
biotechnologyWith an Ebola outbreak declared a public health emergency in the Kampala area, FAS BioCamp 2026 will now run virtually. The program continues — the safety of our fellows and faculty comes first.
Read moreThe Future African Scientist Biotech Pitch Event showcased Africa's first biotech startups, with innovations tackling river blindness, prostate cancer, and antibiotic resistance.
Read more
entrepreneurshipAt the 2026 FAS Biocamp, veterinary scientist Emmanuel Okello taught the cohort to see antimicrobial resistance as a systems failure, and to design diagnostics and ventures that fit the real world, not the ideal lab.
Read more
entrepreneurshipAcross ten lectures at the 2026 FAS Biocamp, Harvey Lodish, lead author of Molecular Cell Biology, showed the cohort the whole arc of modern biotechnology, and how a discovery becomes a medicine.
Read more
entrepreneurshipJing-Ke Weng rebuilds the chemistry that plants invent. At the 2026 FAS Biocamp he showed the cohort how to turn Africa’s plant biodiversity into therapeutics: you do not have to find the plant, you can build the pathway.
Read more
entrepreneurshipJoshua Boger founded Vertex Pharmaceuticals and led it for over twenty years. At the 2026 FAS Biocamp he taught the cohort a harder lesson than success: failure is data, and the mission comes first.
Read more
entrepreneurshipAt the 2026 FAS Biocamp, IP and life sciences lawyer Jurgen Figys taught the cohort to treat intellectual property as commercial strategy, protecting a discovery early so it can grow into a venture that stays home.
Read more
entrepreneurshipAt the 2026 FAS Biocamp, Luis Barros, who has spent 25 years getting science to market across 45 countries, showed the cohort why scarcity is not the enemy of a venture. It is the design.
Read more
biotechnologyAt the 2026 FAS Biocamp, Eclectics International's Sebie Salim walked Africa's scientist-founders from an idea to a profitable venture, with one rule: earn revenue, don't just raise it.
Read more
biotechnologyAt the 2026 FAS Biocamp, Suman Lal, who builds companies out of deep science for a living, showed the cohort how research becomes a venture, and why the customer conversation cannot wait.
Read more